Glucagon-Like Peptide 1 (GLP-1) Agonists Market Trends, Analysis, Forecast

The glucagon-like peptide 1 (GLP-1) agonists is supportive and aims to reduce the severity of the symptoms. Data Bridge Market Research analyses that the glucagon-like peptide 1 (GLP-1) agonists market was valued at 12.55 billion in 2021 and is likely to reach USD 20.15 billion by 2029, and will grow at a CAGR of 6.10% during the forecast period of 2022 to 2029.